JohnWilliamMcGillicuddyMD

PubMed

• 3 citations
  A Critical Analysis of the Specific Pharmacist Interventions and Risk Assessments During the 12-Month TRANSAFE Rx Randomized Controlled Trial:
  Haley M. Gonzales, James N. Fleming, Mulugeta Gebregziabher, Maria Aurora Posadas Salas, John W. McGillicuddy, David J. Taber> ;The Annals of Pharmacotherapy. 2021 Sep 8
• 11 citations
  Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients
  David J. Taber, James N. Fleming, Zemin Su, Patrick D. Mauldin, John W. McGillicuddy, Aurora Posadas, Mulugeta Gebregziabher> ;American Journal of Transplantation. 2021 Jul 1
• 17 citations
  Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety: A Randomized Controlled Clinical Trial.
  Haley M. Gonzales, James N. Fleming, Mulugeta Gebregziabher, Maria Aurora Posadas-Salas, Zemin Su, John W. McGillicuddy, David J. Taber> ;Clinical Journal of the American Society of Nephrology. 2021 May 8
• 13 citations
  Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized contr...
  James N. Fleming, Mulugeta Gebregziabher, Aurora Posadas, Zemin Su, John W. McGillicuddy, David J. Taber> ;American Journal of Health-System Pharmacy. 2021 Jul 9
• 6 citations
  Etiologies and Outcomes Associated with Tacrolimus Levels out of Typical Range that Lead to High Variability in Kidney Transplant Recipients.
  David J. Taber, Jason Hirsch, Alison E Keys, Zemin Su, John W. McGillicuddy> ;Therapeutic Drug Monitoring. 2021 Feb 8
• 4 citations
  Maintaining Equity and Access: Successful Implementation of a Virtual Kidney Transplantation Evaluation.
  Vinayak Rohan, Nicole A. Pilch, Deborah Cassidy, John W. McGillicuddy, Jared White, Angello Lin, David J. Taber, Derek Dubay, Prabhakar K. Baliga> ;Journal of the American College of Surgeons. 2021 Apr 1
• 47 citations
  A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation.
  Haley M. Gonzales, John W. McGillicuddy, Vinayak Rohan, Jessica Chandler, Derek Dubay, David J. Taber> ;American Journal of Transplantation. 2020 Aug 1
• 1 citations
  Patterns of emergency department utilization between transplant and non-transplant centers and impact on clinical outcomes in kidney recipients.
  Haley Perkins, David J. Taber, Neha Patel, Vinayak Rohan, Zemin Su, Derek Dubay, John W. McGillicuddy> ;Clinical Transplantation. 2020 Jul 8
• 24 citations
  Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Con...
  John W. McGillicuddy, Jessica Chandler, Luke Sox, David J. Taber> ;The Annals of Pharmacotherapy. 2020 Jun 8
• 5 citations
  Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: Results of a randomized controlled pilot study.
  David J. Taber, Aurora Posadas-Salas, Zemin Su, Vinaya Rao, Vinayak Rohan, John W. McGillicuddy, Derek Dubay, James N. Fleming> ;Clinical Transplantation. 2020 Apr 1
• 13 citations
  Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients.
  Sunil D. Shenvi, David J. Taber, Andrew D. Hardie, Jonathan Botstein, John W. McGillicuddy> ;HPB. 2020 Jan 1
• 3 citations
  Impact of Type 1 and Type 2 Diabetes Mellitus on Pancreas Transplant Outcomes.
  Vinayak Rohan, David J. Taber, Arun P. Palanisamy, J W McGillicuddy, Kenneth D. Chavin, Prabhakar K. Baliga, Charles F. Bratton> ;Experimental and Clinical Transplantation. 2019 Dec 1
• 3 citations
  Long‐standing diabetes mellitus and pancreas transplantation: An avenue to increase utilization of an ideal treatment modality
  Vinayak Rohan, John W. McGillicuddy, David J. Taber, Prabhakar K. Baliga, Charles F Bratton> ;Clinical Transplantation. 2019 Sep 8
• 23 citations
  Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients.
  David J. Taber, Nicole A. Pilch, John W. McGillicuddy, Caitlin R. Mardis, Frank A. Treiber, James N. Fleming> ;American Journal of Health-System Pharmacy. 2019 Jul 18
• 9 citations
  "Smartphone Medication Adherence Saves Kidneys" for Kidney Transplantation Recipients: Protocol for a Randomized Controlled Trial
  John W. McGillicuddy, Jessica Chandler, Luke Sox, Martina Mueller, Lynne S. Nemeth, Prabhakar K. Baliga, Frank A. Treiber> ;JMIR Research Protocols. 2019 Jun 21
• 5 citations
  Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipients.
  Michelle A. Arms, James N. Fleming, Deep B. Sangani, John W. McGillicuddy, David J. Taber> ;Surgery. 2018 Feb 1
• Feasibility and Functional Testing for Frailty in Chronic Kidney Disease.
  John C. Sieverdes, Vinaya Rao, David J. Taber, Zachary Noltemeyer, John W. McGillicuddy, Marco Bergamin, Sarumathi Thangavel, Prabhakar K. Baliga> ;Progress in Transplantation. 2018 Jun 13
• 13 citations
  Improving Transplant Medication Safety Through a Pharmacist-Empowered, Patient-Centered, mHealth-Based Intervention: TRANSAFE Rx Study Protocol.
  James N. Fleming, Frank A. Treiber, John W. McGillicuddy, Mulugeta Gebregziabher, David J. Taber> ;JMIR Research Protocols. 2018 Mar 2
• 4 citations
  Assessment of risk factors for increased resource utilization in kidney transplantation.
  Steven Craig Vranian, Kelly L. Covert, Caitlin R. Mardis, John W. McGillicuddy, Kenneth D. Chavin, Derek Dubay, David J. Taber> ;The Journal of Surgical Research. 2018 Feb 1
• 52 citations
  Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.
  David J. Taber, Zemin Su, James N. Fleming, John W. McGillicuddy, Maria Aurora Posadas-Salas, Frank A. Treiber, Derek Dubay, Titte R. Srinivas, Patrick D. Mauldin, Wil...> ;Transplantation. 2017 Dec 1
• 2 citations
  Associations Between Medication Nonadherence and Perceived Stress Among Kidney Transplant Recipients.
  Jessica Chandler, Luke Sox, Jenna R. Gunsolley, Frank A. Treiber, John W. McGillicuddy> ;Progress in Transplantation. 2017 Oct 9
• 3 citations
  Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CM...
  James N. Fleming, David J. Taber, Nicole A. Weimert, John W. McGillicuddy, Charles F. Bratton, Prabhakar K. Baliga, Kenneth D. Chavin> ;Transplant Infectious Disease. 2017 Sep 16
• Utilization of the Iliac Artery as Inflow in the Morbidly Obese During Orthotopic Liver Transplantation: A Case Report.
  C.A. Edgerton, John W. McGillicuddy, Derek Dubay> ;Transplantation Proceedings. 2017 Sep 1
• 4 citations
  Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients.
  David J. Taber, J W McGillicuddy, Charles F. Bratton, Vinayak Rohan, Derek A. Dubay, Prabhakar K. Baliga> ;Annals of Surgery. 2017 Sep 1
• 5 citations
  Across state lines: Fulminant Babesia microti infection in a liver transplant recipient
  Eric G. Meissner, John W. McGillicuddy, Jerry E. Squires, Daniel C Skipper, Sally E. Self, Dannah Wray, Erin D. Moritz, Susan L. Stramer> ;Transplant Infectious Disease. 2017 Jul 31
• Join now to see all

Journal Articles

• Valganciclovir (VGCV) Followed by Cytomegalovirus (CMV) Hyperimmune Globulin Compared to VGCV for 200 Days in Abdominal Organ Transplant Recipients at High Risk for CM...  
  Prabhakar K Baliga, John W McGillicuddy, Charles F Bratton, Satish Nadig, Kenneth D Chavin, Transplant Infectious Disease
• Use of Intra‐Aortic Counterpulsation in Cardiogenic Shock Post‐Liver Transplantation  
  Gabriel R Chedister, William D Stoll, Kenneth D Chavin, John W McGillicuddy, Satish N Nadig, David G Koch, Clinical Transplantation